A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemiaChatchada Karanes, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Leukemia Research|1999Cited by 88
Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyBruce J. Roth, Nicholas J. Vogelzang, Lada Krilov et al.|Journal of Clinical Oncology|2012Cited by 63
Cytokines Secreted by Lymphokine-Activated Killer Cells Induce Endogenous Nitric Oxide Synthesis and Apoptosis in DLD-1 Colon Cancer CellsJae‐Yong Kwak, Chang‐Yeol Yim, Myung‐Kwan Han et al.|Cellular Immunology|2000Cited by 57
Longitudinal Assessment of the Nevus Phenotype in a Melanoma KindredScott R. Florell, Sancy A. Leachman, Laurence J. Meyer et al.|Journal of Investigative Dermatology|2004Cited by 38
Failure to Detect Differences in Proliferation Status of Nevi from CDKN2A Mutation Carriers and Non-CarriersScott R. Florell, Sancy A. Leachman, Kenneth M. Boucher et al.|Journal of Investigative Dermatology|2002Cited by 11